PT  - JOURNAL ARTICLE
AU  - Elena Ojeda
AU  - Liliana Moran
AU  - Paula Rodriguez
AU  - Jose Miguel Rodriguez
AU  - Soledad Lopez
AU  - Pilar De Lucas
TI  - BODCAT index: Could we use it instead of BODE or BODEx to classify COPD severity?
DP  - 2014 Sep 01
TA  - European Respiratory Journal
PG  - P3588
VI  - 44
IP  - Suppl 58
4099  - http://erj.ersjournals.com/content/44/Suppl_58/P3588.short
4100  - http://erj.ersjournals.com/content/44/Suppl_58/P3588.full
SO  - Eur Respir J2014 Sep 01; 44
AB  - INTRODUCTION:6-minute walking test (6MWT) is difficult to perform in primary care.Plus,exacerbations are not always correctly reported by patients.OBJECTIVE:To determine the validity and usefulness of modified BODE and BODEx index when classifying the severity of COPD in stable condition by replacing exacerbations and 6MWT by quality of life questionnaire CAT results,easier to perform in primary careMETHOD: 65 patients (mean age 68 years,4% of women,96 % men) treated in our hospital in stable condition.We evaluated FEV1,body mass index,degree of dyspnea by the MRC scale,6MWT,exacerbations in the previous year CAT questionnaire for quality of life.Three index were completed with 6MWT,exacerbations and CAT:BODE ,BODEx,BODCAT. CAT score was stratified: 0-10 one point,11-20 two points,21-30 three points and 31-40 four points.The exacerbations score was stratified:0 no points,1-2 one point,more than 3 two points.The BODE index was scored in the usual way.RESULTS:Correlation (Spearman's Rho ) between BODE,BODCAT and BODEx was significant,in all cases with an r about 0.93-0.94 and p<0.000.We divided patients into two groups:FEV1 > and <50%,and by Pearson correlation, we observed statistically significant differences in the walking test score (p=0.04),and in the CAT index (p<0.000).In both cases that score was higher in group of FEV1<50%,but there was no difference in the exacerbations score.CONCLUSION:The excellent correlation between the analyzed index leads to think about replacing the 6MWT by CAT questionnaire in the assessment COPD.It is necessary to have a larger sample and evaluate by severity stratification, and have a long-term monitoring.